Key Points Question Among patients with hepatocellular carcinoma initially that is beyond the Milan criteria who underwent liver transplant, is an immune checkpoint inhibitor (ICI)–based multimodal pretransplant strategy, which is most often combined with locoregional and/or targeted therapies, associated with better posttransplant outcomes than therapy without ICIs?
Zebin Zhu
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Zebin
Contact Zebin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack